论文部分内容阅读
目的:探讨乙胺碘呋酮(Amiodarone)治疗频发室性早搏的疗效和安全性。方法:本研究选择2010年1月—2013年1月来我院就诊的160例频发室性早搏患者,经乙胺碘呋酮治疗,观察治疗前后的血压、心率、疗效以及不良反应。结果:经乙胺碘呋酮治疗后,160例频发室性早搏的心律失常患者的总有效率为91.88%,治疗后血压、心率有明显的改善,与治疗前比较差异有显著性(P<0.05)。但其中有1例患者出现低血压,2例出现窦性心动过缓,经调整用药剂量后均恢复。结论:乙胺碘呋酮治疗频发室性早搏有明显的疗效,不良反应少,安全可靠,值得在高海拔地区临床工作中推广应用。
Objective: To investigate the efficacy and safety of amiodarone in the treatment of frequent premature ventricular contractions. Methods: In this study, 160 patients with frequent premature ventricular contractions who visited our hospital from January 2010 to January 2013 were treated with amiodarone, and the blood pressure, heart rate, curative effect and adverse reactions were observed before and after treatment. Results: After amiodarone treatment, the total effective rate was 91.88% in 160 patients with frequent premature ventricular arrhythmias. After treatment, the blood pressure and heart rate were significantly improved (P <0.05). However, 1 patient developed hypotension, 2 had sinus bradycardia and recovered after adjustment of dosage. Conclusion: Amiodarone treatment of frequent ventricular premature beats has obvious curative effect, less adverse reactions, safe and reliable, it is worth to promote the clinical work in high altitude areas.